{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:53Z","timestamp":1793600813860,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpeds.2026.115068","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:33:16Z","timestamp":1773765196000},"page":"115068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Differences in Optic Pathway Glioma Prevalence Among Children with Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"294","author":[{"given":"Danae","family":"Kokossis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Hillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny P.","family":"Garzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Listernick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-5045","authenticated-orcid":false,"given":"David H.","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2026.115068_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11060-021-03738-2","article-title":"Racial and ethnic disparities among children with primary central nervous system tumors in the US","volume":"152","author":"Nieblas-Bedolla","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jpeds.2026.115068_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.30975","article-title":"Racial disparities in cancer stage at diagnosis and survival for adolescents and young adults","volume":"7","author":"Taparra","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpeds.2026.115068_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-62702-5.00004-4","article-title":"Neurofibromatosis type 1","volume":"132","author":"Anderson","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jpeds.2026.115068_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2026.115068_bib5","first-page":"101","article-title":"Optic pathway gliomas in neurofibromatosis type 1: an update","volume":"30","author":"de Blank","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jpeds.2026.115068_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2026.115068_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/archopht.119.4.516","article-title":"Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging","volume":"119","author":"Parsa","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jpeds.2026.115068_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpeds.2026.115068_bib9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/neuonc\/noac013","article-title":"Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1","volume":"24","author":"Kotch","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpeds.2026.115068_bib10","doi-asserted-by":"crossref","first-page":"e2214","DOI":"10.1210\/clinem\/dgaa138","article-title":"Pretreatment endocrine disorders due to optic pathway gliomas in children with neurofibromatosis type 1","volume":"105","author":"Santoro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2026.115068_bib11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1177\/08830738251341591","article-title":"Impact of optic pathway gliomas on puberty and growth in neurofibromatosis type 1: a 20-year experience from a tertiary center","volume":"40","author":"Haysom","year":"2025","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jpeds.2026.115068_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/neuonc\/noaa153","article-title":"NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat","volume":"23","author":"Azizi","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpeds.2026.115068_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.24093","article-title":"Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2026.115068_bib14","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/ijc.32187","article-title":"Pediatric malignancies in neurofibromatosis type 1: a population-based cohort study","volume":"145","author":"Peltonen","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jpeds.2026.115068_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10689-015-9855-3","article-title":"Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1","volume":"15","author":"Porcelli","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jpeds.2026.115068_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canep.2016.03.005","article-title":"Peri-gestational risk factors for pediatric brain tumors in neurofibromatosis type 1","volume":"42","author":"Johnson","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jpeds.2026.115068_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canep.2018.04.005","article-title":"Evaluation of racial disparities in pediatric optic pathway glioma incidence: results from the surveillance, epidemiology, and End Results program, 2000-2014","volume":"54","author":"Peckham-Gregory","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jpeds.2026.115068_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpeds.2015.04.076","article-title":"Racial\/ethnic differences in pediatric brain tumor diagnoses in individuals with neurofibromatosis type 1","volume":"167","author":"Abadin","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115068_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1","volume":"127A","author":"Blazo","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2026.115068_bib20","first-page":"280","article-title":"Racial differences in the prevalence of optic nerve gliomas in neurofibromatosis type 1","volume":"57","author":"Saal","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpeds.2026.115068_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/jamia\/ocaf155","article-title":"Comparison of rule- and large language model-based phenotype extraction from clinical notes for neurofibromatosis type 1","volume":"32","author":"Kaster","year":"2025","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jpeds.2026.115068_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1259\/bjr\/65246351","article-title":"Radiological classification of optic pathway gliomas: experience of a modified functional classification system","volume":"81","author":"Taylor","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jpeds.2026.115068_bib23","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s00381-024-06430-8","article-title":"Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions","volume":"40","author":"Kotch","year":"2024","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jpeds.2026.115068_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jdv.17974","article-title":"Identification of three clinical neurofibromatosis 1 subtypes: latent class analysis of a series of 1351 patients","volume":"36","author":"Bergqvist","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jpeds.2026.115068_bib25","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3390\/cancers17091404","article-title":"Predictors in optic pathway gliomas in neurofibromatosis type 1: a single center study","volume":"17","author":"Marja\u0144ska","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jpeds.2026.115068_bib26","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1542\/peds.2010-0188","article-title":"Technical report--racial and ethnic disparities in the health and health care of children","volume":"125","author":"Flores","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.115068_bib27","doi-asserted-by":"crossref","first-page":"13008","DOI":"10.1073\/pnas.0401236101","article-title":"Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects","volume":"101","author":"Reilly","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpeds.2026.115068_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10048-006-0078-5","article-title":"Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies","volume":"8","author":"Hawes","year":"2007","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jpeds.2026.115068_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nor206","article-title":"Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12","volume":"14","author":"Amlin-Van Schaick","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpeds.2026.115068_bib30","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1212\/WNL.0000000000207674","article-title":"Association between socioeconomic factors, race, and use of a specialty memory clinic","volume":"101","author":"Lewis","year":"2023","journal-title":"Neurology"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234762600096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234762600096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:33:35Z","timestamp":1793597615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002234762600096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S002234762600096X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115068","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Optic Pathway Glioma Prevalence Among Children with Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115068"}}